Back Login to subscribe 🔔 Set Alert

EYPT EyePoint, Inc. Common Stock

15 min delay

Loading options…

CALLS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

PUTS

Strike	Last	Bid	Ask	Mark	IV	Volume	OI	Δ Delta	Θ Theta

Loading insider data…

Date	Headline	Sentiment
	RBC Capital Maintains Outperform on EyePoint, Lowers Price Target to $37	95.56%
	Earnings Scheduled For May 6, 2026	69.37%
	Eyepoint Reported $223M Of Cash And Investments As Of March 31, 2026, With Runway Into Q4 2027	93.6%
	EyePoint Pharmaceuticals Q1 EPS $(0.99) Misses $(0.80) Estimate, Sales $696.000K Beat $352.833K Estimate	85.06%